INDRAMEDCO

Indraprastha Medical Corporation share price & financials

Price
₹370.8
Market cap
₹3.3k Cr
Sector
Healthcare

What Indraprastha Medical Corporation Limited does

Indraprastha Medical Corporation Limited operates Indraprastha Apollo Hospitals, a multi-specialty hospital at Sarita Vihar on the Delhi-Mathura Road in New Delhi, and a second hospital in Noida, Uttar Pradesh. The company is affiliated with and operates under the Apollo Hospitals Group brand. It earns revenue by providing in-patient and out-patient medical treatment, along with associated diagnostics and pharmacy services, to patients at these hospital sites.

Hospital locations
2 (Sarita Vihar, New Delhi; Noida, Uttar Pradesh)
Network affiliation
Operates under the Apollo Hospitals Group brand
Founded 1988Headquarters Sarita Vihar, Delhi-Mathura Road, New Delhi - 110076 Company website

Quarterly results

Q1 FY27: revenue up 11.2%, net profit up 9.8% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue350 325 334 365 381 +9%372 +14%365 +9%406 +11%
EBITDA64 52 61 73 71 +11%62 +19%61 +0%80 +10%
Net profit42 33 41 51 49 +17%41 +24%42 +2%56 +10%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −29.7% 1Y

₹400₹500₹600Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹504.65 on 10 Sept 2025 → ₹355. High ₹622.8 (6 Nov 2025), low ₹349.5 (27 Jan 2026).

Financials, as filed

Revenue grew 10.5% a year over 3 years, FY23 to FY26. Operating margin widened to 18.0%.

Year endingFY23FY24FY25FY26
Revenue₹1.1k Cr₹1.2k Cr₹1.4k Cr₹1.5k Cr
Operating profit₹151 Cr₹192 Cr₹244 Cr₹267 Cr
Operating margin13.8%15.4%18.0%18.0%
Interest₹4 Cr₹5 Cr₹7 Cr₹6 Cr
Depreciation₹40 Cr₹40 Cr₹44 Cr₹43 Cr
Net profit₹86 Cr₹123 Cr₹161 Cr₹183 Cr
Net margin7.8%9.9%11.9%12.3%
Cash from operations₹144 Cr₹200 Cr₹157 Cr₹167 Cr
Free cash flow₹100 Cr₹131 Cr₹120 Cr₹108 Cr
ROCE34.0%38.0%39.0%36.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹92 Cr₹92 Cr₹92 Cr₹92 Cr₹92 Cr₹92 Cr
Reserves₹181 Cr₹234 Cr₹288 Cr₹386 Cr₹567 Cr₹649 Cr
Borrowings₹3 Cr₹5 Cr₹2 Cr₹34 Cr₹31 Cr₹37 Cr
Other liabilities₹157 Cr₹131 Cr₹173 Cr₹212 Cr₹264 Cr₹214 Cr
Total liabilities₹432 Cr₹462 Cr₹555 Cr₹723 Cr₹954 Cr₹991 Cr
Fixed assets₹283 Cr₹277 Cr₹275 Cr₹347 Cr₹351 Cr₹365 Cr
Capital work in progress₹3 Cr₹0 Cr₹3 Cr₹0 Cr₹2 Cr₹3 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹39 Cr₹0 Cr
Other assets₹145 Cr₹185 Cr₹278 Cr₹376 Cr₹563 Cr₹624 Cr
Total assets₹432 Cr₹462 Cr₹555 Cr₹723 Cr₹954 Cr₹991 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, DIIs trimmed −2.97 pp while the public added +2.91 pp. The shareholder count grew 7% to 75,098.

Promoters
51.0%
FIIs
2.8%
DIIs
0.6%
Public
45.6%

Since Jun 2025

  • DIIs −2.97 pp
  • Public +2.91 pp
  • FIIs +0.04 pp

How it drifted, 12 quarters

Over this window DIIs fell from 6.7% to 0.6% — −6.1 pp.

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 51.0%, FIIs 0.8%, DIIs 6.7%, Public 41.5%.Dec '23: Promoters 51.0%, FIIs 0.9%, DIIs 6.4%, Public 41.7%.Mar '24: Promoters 51.0%, FIIs 1.1%, DIIs 4.9%, Public 43.0%.Jun '24: Promoters 51.0%, FIIs 1.7%, DIIs 3.1%, Public 44.1%.Sep '24: Promoters 51.0%, FIIs 2.6%, DIIs 3.2%, Public 43.2%.Dec '24: Promoters 51.0%, FIIs 2.9%, DIIs 3.2%, Public 42.9%.Mar '25: Promoters 51.0%, FIIs 2.9%, DIIs 3.6%, Public 42.5%.Jun '25: Promoters 51.0%, FIIs 2.7%, DIIs 3.6%, Public 42.7%.Sep '25: Promoters 51.0%, FIIs 2.4%, DIIs 3.5%, Public 43.1%.Dec '25: Promoters 51.0%, FIIs 2.7%, DIIs 0.8%, Public 45.4%.Mar '26: Promoters 51.0%, FIIs 2.4%, DIIs 0.9%, Public 45.7%.Jun '26: Promoters 51.0%, FIIs 2.8%, DIIs 0.6%, Public 45.6%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Indraprastha Medical Corporation Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
President Of India 26.00%unchanged
Apollo Hospitals Enterprises Limited 22.02%unchanged
Vanaja Sundar Iyer 1.97%unchanged
Emedlife Insurance Broking Services Limited 1.70%unchanged
Wedgewood Holdings Limited 1.61%unchanged
Citadel Research And Solutions Limited 1.29%unchanged
Investor Education and Protection Fund 1.09%newly disclosed
M/s. PCR Investments Ltd 0.42%unchanged
Dr. Prathap C Reddy 0.26%unchanged
Ms. Preetha Reddy 0.22%unchanged
Ms. Sucharitha P Reddy 0.18%unchanged
Ms. Suneeta Reddy 0.15%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Attractive

To justify its price of ₹355, this stock must grow earnings at 11% every year for 7 years. Our analysis caps realistic growth at ~29%. At that growth it is worth ₹889 — upside of 150%.

Growth the price implies
10.9% a year
for 7 years, fading to 4%
It has actually compounded at
28.6% a year
net profit, FY23–FY26 · EPS 28.7%
The gap
-0.2 pp
150% downside if it only repeats history
Price today ₹355 Value at the reference growth ₹888.98

Change the assumptions yourself →

Learn to analyse Indraprastha Medical Corporation Limited

Guides on how to read this kind of business and the numbers that matter.